Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (OTCQB:PVCT)

During the Trading Day
0.0371 -0.0099 / -21.06%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.0419 +0.0048 / +12.99%
Volume: --
Health Technology
Pharmaceuticals: Other

Company Description

Provectus Biopharmaceuticals, Inc. engages in the development of pharmaceuticals for oncology and dermatology indications. Its products include PV-10 and PH-10. The company was founded on January 17, 2002 and is headquartered in Knoxville, TN.

Contact Information

Provectus Biopharmaceuticals, Inc.
7327 Oak Ridge Highway
Knoxville Tennessee 37931
P:(866) 594-5999
Investor Relations:



Individual stakeholders3.53%
Other institutional0.05%
Mutual fund holders0.00%

Top Executives

Timothy C. ScottPresident, Chief Executive Officer & Director
John R. GlassChief Financial Officer
Eric A. WachterChief Technology Officer & Director